FDA FORMING TASK FORCE TO CONSIDER OTC ANALGESIC INDICATIONS
This article was originally published in The Tan Sheet
Executive Summary
FDA FORMING TASK FORCE TO CONSIDER OTC ANALGESIC INDICATIONS for Rx-to-OTC switch reviews, Pilot Drug Evaluation Staff Acting Director Linda Katz, MD, reported to the agency's Arthritis Advisory Committee on Jan. 28. Katz said that the decision to form the task force was due to "some of the comments and concerns that were raised at the last two advisory committee meetings." FDA's Center for Drug Evaluation and Research will oversee the establishment of the task force.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning